stenting: επαναστένωση isr (intra stent restenosis)
DESCRIPTION
Stenting: επαναστένωση ISR (intra stent restenosis). Μετεκπαιδευτικό Πρόγραμμα στην Αγγειοχειρουργική - Ενδαγγειακή Χειρουργική. Κ. Α. Φίλης Επίκ. Καθηγητής ΕΚΠΑ. Definitions ISR can be defined clinically or angiographically. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/1.jpg)
Stenting:επαναστένωσηISR (intra stent restenosis)
Μετεκπαιδευτικό Πρόγραμμα στην Αγγειοχειρουργική - Αγγειοχειρουργική - Ενδαγγειακή ΧειρουργικήΕνδαγγειακή Χειρουργική
Κ. Α. ΦίληςΚ. Α. ΦίληςΕπίκ. Καθηγητής ΕΚΠΑΕπίκ. Καθηγητής ΕΚΠΑ
![Page 2: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/2.jpg)
Definitions
ISRISR can be definedcan be defined clinically clinically oror angiographically.angiographically.
Clinically, it is defined as the presentation of recurrent ischaemia
Angiographically, ISR is the presence of >50% diameter stenosis in the stented segment.
50%-70% : moderate 70%-99% : severe
Teirstein PS,
N Engl J Med, 1997
![Page 3: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/3.jpg)
Cellular response to injuryCellular response to injury
• Platelet adherence and degranulation (10-30min)– Subenthothelial collagen exposure
– Platelets adherence (αΙΙb βIΙa, Von Villebrand, Fibronectin)
– ADP, thromboxane A2,
– Platelets recruitment (αΙΙb βΙΙIa)
– Platelets degranulation (PDGF)
• Leukocyte, monocytes, macrophages • SMC proliferation and migration (1day – 3months)
• Endothelial cell regrowth
![Page 4: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/4.jpg)
![Page 5: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/5.jpg)
![Page 6: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/6.jpg)
Diffuse in stent restenosisDiffuse in stent restenosis
![Page 7: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/7.jpg)
Initial role of stents : optionalInitial role of stents : optional
to support the dissected ballooned plaque from further dissection-rupture
to prevent arterial recoil by their radial force
![Page 8: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/8.jpg)
![Page 9: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/9.jpg)
PTA result
PTA result
![Page 10: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/10.jpg)
Το δίλημμα
• Αγγειοπλαστική με μπαλόνι– Constrictive remodeling (αναδιαμόρφωση σύσπασης)– Elastic recoil (ελαστική επαναφορά)
• Αγγειοπλαστική με ενδοπρόθεση– Αυξημένη μυο-ενδοθηλιακή υπερπλασία
![Page 11: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/11.jpg)
Intimal hyperplasia
![Page 12: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/12.jpg)
![Page 13: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/13.jpg)
![Page 14: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/14.jpg)
![Page 15: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/15.jpg)
Various ISR rates @ 1 year according to locations
![Page 16: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/16.jpg)
Time course of ISR
![Page 17: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/17.jpg)
Factors influencing ISRFactors influencing ISR
![Page 18: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/18.jpg)
Cardiovascular factorsCardiovascular factors
Smoking
Diabetes
Hyperlipidemia
![Page 19: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/19.jpg)
Effect of smoking in ISREffect of smoking in ISRCardiovascular factorsCardiovascular factors
![Page 20: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/20.jpg)
Effect of diabetes in ISREffect of diabetes in ISRCardiovascular factorsCardiovascular factors
P=0.89 (NIDM)P=0.04 (IDM)
![Page 21: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/21.jpg)
Genomic
Blood flow
Plaque
![Page 22: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/22.jpg)
GenomicGenomicEndogenous factorsEndogenous factors
![Page 23: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/23.jpg)
Blood flowBlood flowEndogenous factorsEndogenous factors
![Page 24: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/24.jpg)
PlaquePlaqueEndogenous factorsEndogenous factors
![Page 25: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/25.jpg)
Endogenous factorsEndogenous factors
![Page 26: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/26.jpg)
Endogenous factorsEndogenous factors
![Page 27: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/27.jpg)
Endogenous factorsEndogenous factors
![Page 28: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/28.jpg)
Endogenous factorsEndogenous factors
![Page 29: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/29.jpg)
Exogenous factorsExogenous factors
Stent
![Page 30: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/30.jpg)
Exogenous factorsExogenous factors
StentStent
ΕυλυγισίαΠάχοςΕυκολία καθοδήγησης
Ακτινική δύναμη
ΒιοσυμβατότηταΜηχανική αντοχήΑντίσταση στη ρήξη
![Page 31: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/31.jpg)
Stent asymetryStent asymetryExogenous factorsExogenous factors
![Page 32: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/32.jpg)
Self expanding Self expanding VV balloon expanded balloon expandedExogenous factorsExogenous factors
![Page 33: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/33.jpg)
Cell designCell designExogenous factorsExogenous factors
![Page 34: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/34.jpg)
Strut ThicknessStrut ThicknessExogenous factorsExogenous factors
![Page 35: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/35.jpg)
Stent fractureStent fractureExogenous factorsExogenous factors
![Page 36: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/36.jpg)
Restenosis-ThrombosisPharmacologic prevention
ASA & Heparin
ASA & Ticlopidin
![Page 37: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/37.jpg)
Restenosis-ThrombosisPharmacologic prevention
![Page 38: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/38.jpg)
![Page 39: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/39.jpg)
Gold standard : Clopidogrel + aspirin
![Page 40: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/40.jpg)
Σημασία των αντιαιμοπεταλιακών
• Αναστολή αιμοπεταλιακής δραστικότητας με σκοπό την πρόληψη της οξείας θρόμβωσης της αγγειοπλαστικής
• Ανεπαρκή για την επαναστένωση
![Page 41: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/41.jpg)
Prevention of ISR
• Medicines
• Drug eluting stents
• Brachytherapy, Cryoplasty
• Genes
![Page 42: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/42.jpg)
MedicinesMedicines ISR on coronary PTA/stent
PDGF I
antiallergic
Reo pro
![Page 43: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/43.jpg)
Induction of vascular atrophy as a novel approach to treating restenosis. A review
Seung-Kee Min MDa, Richard D. Kenagy PhDb and Alexander W. Clowes MDb, ,
After vascular reconstruction, luminal narrowing is in part caused by
intimal thickeningintimal thickening, the consequence of endothelial injury and endothelial injury and
inflammationinflammation, smooth muscle cell hyperplasiasmooth muscle cell hyperplasia, , and extracellular matrix extracellular matrix
accumulationaccumulation. It may be possible to induce these lesions to shrink.
This novel approach to the treatment of restenosis is supported by animal
experiments and a few clinical observations demonstrating vascular
atrophy in response to drugs such as Gleevec (EDGF I).
A potential limitation to this approach might be the formation of
aneurysms.
Journal of Vascular SurgeryVolume 47, Issue 3, March 2008, Pages 662-670
![Page 44: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/44.jpg)
Drug eluting stents
sirolimus
results from coronary
paclitaxel
DES inhibit smooth muscle cells and endothelial cells
1. They inhibit ISR
2. They are more thrombogenic
Clinical practice : no benefit in survival, no benefit in MACE,
But fewer reinterventions to keep the artery patent
![Page 45: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/45.jpg)
DES in cardiac & peripheral arteries
![Page 46: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/46.jpg)
Drug eluting stents in peripheral Drug eluting stents in peripheral arteriesarteries
J Endovasc Ther. 2009 Jun;16(3):251-60.Infragenicular stent implantation for below-the-knee atherosclerotic disease:clinical evidence from an international collaborative meta-analysis on 640 patients.Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, Agostoni P, Bosiers M, Peregrin J, Rosales O, Cotroneo AR, Rand T, Sheiban I.
Head-to-head comparisons showed that sirolimus-eluting stents sirolimus-eluting stents were superior to balloon-expandable bare metal stents in were superior to balloon-expandable bare metal stents in preventing restenosis and increasing primary patencypreventing restenosis and increasing primary patency (both p<0.001); sirolimus-eluting stents were also better than paclitaxel-eluting stents in terms of primary patency (p<0.001) and repeat revascularizations (p = 0.014).
![Page 47: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/47.jpg)
BrachytherapyBrachytherapy
![Page 48: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/48.jpg)
Gene therapyGene therapy
• Genetically engineered cells secreting a
thrombolytic enzyme (tPA) which are topically
applied (on the stent).
• Major problem : cells are moving away by the
blood flow.
![Page 49: Stenting: επαναστένωση ISR (intra stent restenosis)](https://reader035.vdocuments.net/reader035/viewer/2022062518/56814908550346895db6408a/html5/thumbnails/49.jpg)
ConclusionsConclusions
ISR is a stable endothelial reaction to injurySTRATEGIES TO INHIBIT ISRSTRATEGIES TO INHIBIT ISR
systematic topicalsystematic topical Medicines DES, Drug eluting balloonsedicines DES, Drug eluting balloons
Brachytherapy, Brachytherapy, CryoplastyCryoplasty
Photodynamic therapy Photodynamic therapy
GenesGenes